Jan 27, 2026 07:00AM
Jan 27, 2026 07:00AM
Jan 8, 2026 08:00AM
Dec 21, 2025 04:00AM
Aug 13, 2025 08:00AM
Mar 11, 2024 04:10PM
Jan 24, 2024 08:01AM CytomX Therapeutics (CTMX) Announces FDA Clearance of IND Applications for CX-2051
Jan 24, 2024 08:00AM
Nov 17, 2022 07:01AM
Nov 17, 2022 07:00AM
Nov 17, 2022 07:00AM
Sep 7, 2022 06:05PM
Jul 7, 2022 09:26AM
Jul 6, 2022 04:06PM CytomX Therapeutics (CTMX) Announces Phase 2 Study of Praluzatamab Ravtansine Met Primary Endpoint
Jul 6, 2022 04:05PM
May 5, 2022 04:15PM
Mar 1, 2022 04:15PM
Jan 19, 2022 08:01AM
Jan 19, 2022 08:00AM
Nov 4, 2021 04:15PM
Aug 5, 2021 04:15PM CytomX Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update
Jan 20, 2021 09:20AM
Jan 19, 2021 05:44PM
Dec 29, 2020 07:42AM
Mar 24, 2020 09:14AM
Nov 20, 2019 09:16AM
Nov 19, 2019 05:57PM
Feb 27, 2019 04:08PM CytomX Therapeutics Announces Full-Year 2018 Financial Results
Nov 6, 2018 04:05PM
Aug 8, 2018 04:04PM
May 22, 2018 07:32AM
May 22, 2018 07:30AM
Nov 28, 2017 08:34AM
Nov 28, 2017 08:30AM
Oct 4, 2017 09:30AM Pre-Open Stock Movers 10/04: (CTMX) (CATB) (MYL) Higher; (CLSN) (MNTA) (TEVA) (ODP) Lower (more...)
Oct 3, 2017 04:05PM
Sep 21, 2017 08:00AM
Mar 20, 2017 09:29AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All